Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study

Role of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor Gene on Cardiovascular Risk Factors and Weight Loss after Biliopancreatic Diversion Surgery

(2014) Daniel Antonio de Luis et al.   ANNALS OF NUTRITION AND METABOLISM

Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome

(2014) Mojca Jensterle et al.   ENDOCRINE RESEARCH

Ensembl 2015

(2014) Fiona Cunningham et al.   NUCLEIC ACIDS RESEARCH

Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes

(2014) Kenjiro Imai et al.   Diabetology & Metabolic Syndrome

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study

(2014) Christina B. Rasmussen et al.   Frontiers in Endocrinology

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease

(2013) H. Kahal et al.   CLINICAL ENDOCRINOLOGY

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

(2013) Mojca Jensterle Sever et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

(2013) M E J Lean et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS

(2013) L van Bloemendaal et al.   JOURNAL OF ENDOCRINOLOGY

Minireview: Signal Bias, Allosterism, and Polymorphic Variation at the GLP-1R: Implications for Drug Discovery

(2013) Cassandra Koole et al.   MOLECULAR ENDOCRINOLOGY

Glucagon-like peptide 1 and appetite

(2013) Megan J. Dailey et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The central GLP-1: implications for food and drug reward

(2013) Karolina P. Skibicka   Frontiers in Neuroscience

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

(2012) K. Niswender et al.   DIABETES OBESITY & METABOLISM

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis

(2012) S.S. Lim et al.   HUMAN REPRODUCTION UPDATE

GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

(2012) Juris J. Meier   Nature Reviews Endocrinology

The structure and function of the glucagon-like peptide-1 receptor and its ligands

(2011) Dan Donnelly   BRITISH JOURNAL OF PHARMACOLOGY

Third intracellular loop of glucagon like-peptide-1 receptor is coupled with endogenous mono-ADP-ribosyltransferase — Novel type of receptor regulation?

(2011) Matjaž Deželak et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

(2011) A Astrup et al.   INTERNATIONAL JOURNAL OF OBESITY

The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma

(2011) Nina Erčulj et al.   Pharmacogenetics and Genomics

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study

(2010) A. Sathananthan et al.   DIABETES CARE

Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome

(2008) Karen Elkind-Hirsch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM